Photo: David Becker/Getty Images

Sen. Elizabeth Warren surged to 19% and second place in a CBS News/YouGov national poll released Sunday, trailing front-runner Sen. Bernie Sanders (28%) but edging out Joe Biden (17%) and Michael Bloomberg (13%).

Why it matters: The poll notes that only 42% of Democratic primary voters have made up their minds. While Warren underperformed in the first three states, her strong debate performance in Nevada last week may have given her campaign new life.

  • 50% of respondents to Sunday's poll said Warren's performance in recent debates — including Wednesday's, where she ripped into the billionaire Bloomberg for his history of sexist remarks — impressed them the most out of any candidate.
  • The Warren campaign said Saturday that it has raised $14 million in the 10 days since the New Hampshire primary.

By the numbers:

  • Bernie Sanders: 28%
  • Elizabeth Warren: 19%
  • Joe Biden: 17%
  • Michael Bloomberg: 13%
  • Pete Buttigieg: 10%
  • Amy Klobuchar: 5%

The big picture: 65% of voters nationwide believe President Trump will be re-elected in November, according to the poll. Sen. Bernie Sanders — who just turned in a dominant performance in the Nevada caucuses — fares the best in a head-to-head matchup against Trump, but the margin appears slim no matter who the Democratic nominee is.

  • Sanders (47%) vs. Trump (44%)
  • Biden (47%) vs. Trump (45%)
  • Warren (46%) vs. Trump (45%)
  • Buttigieg (44%) vs. Trump (44%)
  • Klobuchar (44%) vs. Trump (45%)
  • Bloomberg (42%) vs. Trump (45%)

Methodology: The CBS News/YouGov poll was conducted between Feb. 20–22. It surveyed 10,000 registered voters, including 6,498 self-identified Democrats and independents who plan to vote in the Democratic primaries. The margin of error for the whole sample is 1.2%, while the likely Democratic voter sample's margin of error is 1.7%.

Go deeper: Warren and Sanders raise millions after Nevada debate

Go deeper

Updated 25 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 7:30 p.m. ET: 13,258,016 — Total deaths: 576,752 — Total recoveries — 7,366,845Map.
  2. U.S.: Total confirmed cases as of 7:30 p.m. ET: 3,416,222 — Total deaths: 136,319 — Total recoveries: 1,049,098 — Total tested: 41,764,557Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

2 hours ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."